Cargando…
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
T- and NK-cell lymphomas (TCL) are a heterogenous group of lymphoid malignancies with poor prognosis. In contrast to B-cell and myeloid malignancies, there are few preclinical models of TCLs, which has hampered the development of effective therapeutics. Here we establish and characterize preclinical...
Ejemplares similares
-
First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models
por: Pairawan, Seyed, et al.
Publicado: (2021) -
Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects
por: Dempster, Joshua M., et al.
Publicado: (2021) -
Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry
por: Durbin, Adam D., et al.
Publicado: (2018) -
Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity
por: Zhou, Xiaolei, et al.
Publicado: (2021) -
Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal
por: Krill-Burger, J. Michael, et al.
Publicado: (2023)